Lv7
4960 积分 2022-06-30 加入
Pembrolizumab for Early Triple-Negative Breast Cancer
6个月前
已完结
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
6个月前
已完结
Real-World Application of Alliance ACOSOG Z11102: How Many Patients Can be Spared Mastectomy?
6个月前
已完结
KL610023: A Novel SN38-Prodrug with a Spontaneous Cleavage Mechanism
10个月前
已关闭
Comprehensive preclinical pharmacokinetic evaluations of trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate, in cynomolgus monkeys
10个月前
已完结
Deep Learning Model for Predicting Immunotherapy Response in Advanced Non−Small Cell Lung Cancer
1年前
已完结
Utidelone Plus Bevacizumab for ERBB2-Negative Metastatic Breast Cancer and Active Brain Metastases: The U-BOMB Phase 2 Nonrandomized Clinical Trial
1年前
已完结
皖公网安备34019202002308
